DK1735330T3 - Progesteronreceptormodulatorer - Google Patents

Progesteronreceptormodulatorer

Info

Publication number
DK1735330T3
DK1735330T3 DK05733590T DK05733590T DK1735330T3 DK 1735330 T3 DK1735330 T3 DK 1735330T3 DK 05733590 T DK05733590 T DK 05733590T DK 05733590 T DK05733590 T DK 05733590T DK 1735330 T3 DK1735330 T3 DK 1735330T3
Authority
DK
Denmark
Prior art keywords
progesterone receptor
progesterone
receptor
Prior art date
Application number
DK05733590T
Other languages
English (en)
Inventor
Johannes Antonius Mar Hamersma
Johannes Bernardus Ma Rewinkel
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Application granted granted Critical
Publication of DK1735330T3 publication Critical patent/DK1735330T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/001—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class spiro-linked

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK05733590T 2004-03-25 2005-03-18 Progesteronreceptormodulatorer DK1735330T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55621004P 2004-03-25 2004-03-25
EP04101241 2004-03-25
PCT/EP2005/051265 WO2005092912A1 (en) 2004-03-25 2005-03-18 Progesterone receptor modulators

Publications (1)

Publication Number Publication Date
DK1735330T3 true DK1735330T3 (da) 2008-03-31

Family

ID=34928929

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05733590T DK1735330T3 (da) 2004-03-25 2005-03-18 Progesteronreceptormodulatorer

Country Status (29)

Country Link
US (1) US7691836B2 (da)
EP (1) EP1735330B1 (da)
JP (1) JP4922918B2 (da)
KR (1) KR20070028355A (da)
CN (1) CN100549023C (da)
AR (1) AR048330A1 (da)
AU (1) AU2005225560B2 (da)
BR (1) BRPI0509153A (da)
CA (1) CA2560694C (da)
CY (1) CY1107132T1 (da)
DE (1) DE602005003564T2 (da)
DK (1) DK1735330T3 (da)
EC (1) ECSP066881A (da)
ES (1) ES2297699T3 (da)
IL (1) IL178010A0 (da)
LV (1) LV13527B (da)
MX (1) MXPA06010906A (da)
MY (1) MY143074A (da)
NO (1) NO20064822L (da)
NZ (1) NZ549862A (da)
PE (1) PE20060094A1 (da)
PL (1) PL1735330T3 (da)
PT (1) PT1735330E (da)
RU (1) RU2381232C2 (da)
SI (1) SI1735330T1 (da)
TW (1) TW200531977A (da)
UA (1) UA88782C2 (da)
WO (1) WO2005092912A1 (da)
ZA (1) ZA200607801B (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016090139A1 (en) * 2014-12-03 2016-06-09 Evestra, Inc. Combination of estrogens plus antiprogestins with significant partial agonistic effect as an effective treatment of menopausal symptoms and for prevention of the occurrence of breast cancer

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE290198C (da)
GB8513723D0 (en) 1985-05-31 1985-07-03 Erba Farmitalia 11-beta substituted steroids
IE60780B1 (en) 1987-01-23 1994-08-10 Akzo Nv New 11-aryl steroid derivatives
DE3866410D1 (de) 1987-04-24 1992-01-09 Akzo Nv 11-arylestranderivate und 11-arylpregnanderivate.
DE19975054I2 (de) 1987-08-08 2000-04-13 Akzo Nobel Nv Kontrazeptives Implantat
DE3822770A1 (de) * 1988-07-01 1990-01-04 Schering Ag 13-alkyl-11ss-phenylgonane
DD290198A5 (de) * 1989-09-18 1991-05-23 Zi Fuer Mikrobiologie Und Experimentelle Therapie Jena,De Verfahren zur herstellung von 11 beta-arylsubstituierten estra-4,9-dien-3-on-17(s)-spiro-1'-cyclohexan-2'-onen und 11 beta-arylsubstituierten estra-4,9-dien-3-on-17(s)-spiro-1'-cyclohexan-2'-olen sowie deren derivate
FR2658516B1 (fr) 1990-02-22 1992-06-12 Roussel Uclaf Nouveaux produits sterouides comportant un radical spiro en position 17, leur procede de preparation et les intermediaires de ce procede, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
ZA929315B (en) 1991-12-20 1993-05-24 Akzo Nv 17-spirofuran-3'-ylidene steroids.
CA2100514C (en) 1992-07-29 2005-03-29 Johannes A. M. Hamersma 17-spiromethylene steroids
US5688808A (en) 1994-12-22 1997-11-18 Ligand Pharmaceuticals Incorporated Steroid receptor modulator compounds and methods
ATE213947T1 (de) 1996-06-25 2002-03-15 Akzo Nobel Nv Progestogen-anti-progestogen therapien
IL123813A0 (en) 1997-04-11 1998-10-30 Akzo Nobel Nv Drug delivery system for two or more active substances
AU747710B2 (en) 1997-11-14 2002-05-23 Akzo Nobel N.V. Progestogen-antiprogestogen regimens
US6020328A (en) * 1998-03-06 2000-02-01 Research Triangle Institute 20-keto-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
US6172052B1 (en) * 1998-12-04 2001-01-09 Research Triangle Institute 17β-acyl-17α-propynyl-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties

Also Published As

Publication number Publication date
US7691836B2 (en) 2010-04-06
LV13527B (en) 2007-04-20
ECSP066881A (es) 2006-11-24
MY143074A (en) 2011-02-28
AU2005225560B2 (en) 2011-01-27
RU2381232C2 (ru) 2010-02-10
NZ549862A (en) 2010-01-29
TW200531977A (en) 2005-10-01
CN1934125A (zh) 2007-03-21
UA88782C2 (en) 2009-11-25
IL178010A0 (en) 2006-12-31
NO20064822L (no) 2006-10-24
PT1735330E (pt) 2007-12-21
MXPA06010906A (es) 2007-03-08
DE602005003564T2 (de) 2008-10-23
AR048330A1 (es) 2006-04-19
SI1735330T1 (sl) 2008-04-30
BRPI0509153A (pt) 2007-11-20
WO2005092912A1 (en) 2005-10-06
CY1107132T1 (el) 2012-10-24
ZA200607801B (en) 2008-07-30
HK1096405A1 (en) 2007-06-01
KR20070028355A (ko) 2007-03-12
EP1735330B1 (en) 2007-11-28
PL1735330T3 (pl) 2008-05-30
DE602005003564D1 (de) 2008-01-10
CA2560694A1 (en) 2005-10-06
CN100549023C (zh) 2009-10-14
RU2006137578A (ru) 2008-04-27
CA2560694C (en) 2012-03-06
JP4922918B2 (ja) 2012-04-25
JP2007530501A (ja) 2007-11-01
ES2297699T3 (es) 2008-05-01
AU2005225560A1 (en) 2005-10-06
EP1735330A1 (en) 2006-12-27
US20070203105A1 (en) 2007-08-30
PE20060094A1 (es) 2006-02-24

Similar Documents

Publication Publication Date Title
DK2081951T3 (da) Progesteron-receptorantagonister
DK2653465T3 (da) Opioid-receptormodulatorer
DE602005016187D1 (de) Staubreduzierende Einrichtung
DE602005012730D1 (de) Lk-kommunikationsgerät
ATE382034T1 (de) Hydroisoindolin-tachykininrezeptorantagonisten
DE502005007052D1 (de) Sitzbefestigungsvorrichtung
DK1973886T3 (da) Prokineticin-1-receptor-antagonister
DE602005021211D1 (de) Befestigungsvorrichtung
DE502005001883D1 (de) Anschlussvorrichtung
FR2875801B1 (fr) Coulis de ciment-mousse
DE602005002678D1 (de) Anschlussvorrichtung
DE502005000496D1 (de) Verstellvorrichtung
DE502005006735D1 (de) Stelleinrichtung
ITMI20061101A1 (it) Gattuccio
DE502005002806D1 (de) Mischvorrichtung
DE602006005138D1 (de) Nichtsteroide glucocorticoid-rezeptormodulatoren
ATE478078T1 (de) Pyridooxazepin-progesteronrezeptor-modulatoren
DE502004012222D1 (de) Fadenaufhol-Vorrichtung
AT500444B8 (de) Verbindungsvorrichtung
DE602005012509D1 (de) Kegelspielvorrichtung
GB0414798D0 (en) Receptor
DE602005003564D1 (de) Progesteronrezeptormodulatoren
DE502005007053D1 (de) Verbindungseinrichtung
DE112005002293A5 (de) Verstelleinrichtung
ATE551034T1 (de) Urinaufnehmer